Company intelligence / Profile preview

HeraMED

Ownership: Private
Development stage: Commercial

Overview

HeraMED has developed a commercially available, medically validated remote maternity care platform (HeraCARE) and a home-use fetal/maternal heart rate monitor device (HeraBEAT). The technology is implemented in real-world settings with demonstrated reductions in in-office visits, increased vitals capture, high patient/provider satisfaction, and growing global adoption. Clinical results show equivalence to standard clinic assessments for low-risk pregnancies.

Therapeutic areas: Women's Health
Modalities: DeviceNon-pharmacological therapy
Industry: Physiological Monitoring

Partnerships

Telstra Health Connected Care EcosystemRamsey Health Care’s Joondalup Health CampusIsrael Innovation AuthorityHofon Pharma

Beyond the preview

Go deeper on HeraMED.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HeraMED.

Explore the full profile